The UK's most complete GLP-1 guide
Every Question Answered. Every Side Effect Explained.
- How GLP-1 medications work
- Mounjaro vs Wegovy compared
- Injection instructions
- Side effects & solutions
- What to eat on treatment
- FAQs answered
Free tracker included with every download this week
Mounjaro and Kidney Pain — What UK Patients Need to Know
Kidney pain is not listed as a common side effect of Mounjaro (tirzepatide) in UK clinical data, but it's important to understand what kidney-related symptoms might indicate and when to contact your GP. This guide explains the connection between GLP-1 and GIP receptor agonists like Mounjaro and kidney health, helps you identify genuine kidney concerns versus other abdominal pain, and outlines when medical advice is necessary. If you're considering Mounjaro or currently taking it, understanding potential health impacts is essential for safe use.
10,000+ calculations today · NHS-aligned thresholds · 100% free
Calculate Your BMI Instantly
Enter your height and weight below. Supports both imperial (stone & lbs) and metric (kg). Results include NHS category, healthy weight range, and ethnicity adjustments.
What Is BMI and Why Does It Matter?
Body Mass Index (BMI) is the most widely used screening tool for assessing whether your weight falls within a healthy range. Used by the NHS, GPs, and weight management services across the UK, BMI provides a quick snapshot of your weight relative to your height. The formula is simple: your weight in kilograms divided by your height in metres squared (kg/m²).
While BMI isn't a perfect measure — it doesn't account for muscle mass, bone density, or fat distribution — it remains the standard first step in identifying potential weight-related health risks including type 2 diabetes, cardiovascular disease, high blood pressure, and certain cancers.
The NHS also recommends adjusted thresholds for people of South Asian, Chinese, or Black African heritage — a BMI of 23 or above is classified as overweight, and 27.5 as obese. Our calculator includes this adjustment as a one-click toggle.
Understanding Mounjaro and Kidney Function
Mounjaro (tirzepatide) is a dual GIP and GLP-1 receptor agonist approved in the UK for weight management in eligible adults. Kidney pain is not listed as a common or very common side effect in the UK product information, though stomach and abdominal pain affects more than 1 in 10 people taking the medication.
However, kidney function becomes relevant in certain situations: people with severe kidney disease may require dose adjustments or may not be suitable for Mounjaro at all. Additionally, gradual weight management itself can occasionally trigger kidney-related changes, and dehydration—which can occur with nausea and diarrhoea (common Mounjaro side effects)—may temporarily affect kidney function.
If you experience pain in the lower back or sides (typical kidney pain location), this warrants investigation to rule out kidney stones, urinary tract infection, or other urological causes. Always contact your GP if abdominal or back pain is severe, persistent, or accompanied by changes in urination, fever, or blood in urine.
Clinically BackedWeight Loss
No appointments. No waiting rooms. Just care — from a UK-regulated online pharmacy.
How It Works
Three simple steps to understand your weight and take action.
Enter your height and weight in our free calculator. Get your BMI, NHS category, healthy weight range, and ethnicity-adjusted thresholds instantly.
If your BMI suggests you're overweight or obese, explore our GLP-1 calculators to project potential weight loss on Mounjaro or Wegovy.
Use our progress tracker to log your weight weekly, visualise your journey with charts, and stay motivated — all stored privately in your browser.
Free Weight Loss Tools & Guides
Everything you need to understand your weight, explore medication options, and track your progress — completely free.
Kidney Health and GLP-1 Medications — What Research Shows
Research on GLP-1 receptor agonists—including semaglutide (Wegovy) and liraglutide (Saxenda)—has actually shown protective effects on kidney function in people with type 2 diabetes. Clinical trials indicate that GLP-1 agonists may help preserve kidney function and reduce proteinuria (protein in urine).
Mounjaro's dual mechanism has shown similar benefits in early data. The key factor is maintaining adequate hydration while taking Mounjaro, especially during the initial weeks when nausea and diarrhoea are most common. Dehydration can temporarily reduce kidney filtration and should be avoided.
Before starting Mounjaro, your GP or prescriber will assess your kidney function through blood tests (measuring creatinine and eGFR). If you have moderate to severe kidney disease, Mounjaro dosing may need adjustment or the medication may not be suitable. Always inform your healthcare provider of any kidney conditions before starting treatment.
- Dual GIP/GLP-1 receptor agonist
- Up to 22.5% body weight loss (SURMOUNT-1)
- Weekly injection, dose escalation over 20+ weeks
- Available via private prescription in the UK
- Doses: 2.5mg → 5mg → 7.5mg → 10mg → 12.5mg → 15mg
- GLP-1 receptor agonist
- Up to 15–17% body weight loss (STEP trials)
- Weekly injection, 5-step dose escalation
- NHS & private prescription available
- Doses: 0.25mg → 0.5mg → 1mg → 1.7mg → 2.4mg
Mounjaro vs Wegovy: Head-to-Head
A side-by-side comparison of the two most popular GLP-1 weight loss medications available in the UK.
| Feature | Mounjaro | Wegovy |
|---|---|---|
| Drug class | Dual GIP/GLP-1 agonist | GLP-1 agonist |
| Active ingredient | Tirzepatide | Semaglutide |
| Avg. weight loss | 15–22.5% | 12–17% |
| Key trial | SURMOUNT-1 (2022) | STEP 1 (2021) |
| Max dose | 15 mg weekly | 2.4 mg weekly |
| Escalation period | 20–32 weeks | 16–20 weeks |
| Administration | Weekly injection (pen) | Weekly injection (pen) |
| NHS availability | Private prescription only | NHS & private |
| Approx. private cost | £150–£250/month | £150–£300/month |
| Common side effects | Nausea, diarrhoea, constipation | Nausea, vomiting, diarrhoea |
Data sourced from SURMOUNT-1 and STEP 1 clinical trials. Costs are approximate and vary by provider. Always consult a prescriber.
Am I Eligible for Weight Loss Medication?
In the UK, eligibility for GLP-1 weight loss medications like Mounjaro and Wegovy is based on your BMI and overall health profile.
- BMI of 30 or above (obese)
- Age 18 or over
- No contraindicated conditions
- Committed to lifestyle changes
- BMI of 27 or above
- Plus type 2 diabetes
- Or high blood pressure
- Or obstructive sleep apnoea
Use our BMI calculator to check whether your BMI falls within the eligible range.
How We Built These Tools
Every calculator and guide on myweightcheck is built with accuracy and transparency in mind. Our BMI calculator uses the standard WHO formula with NHS-aligned category thresholds. Our GLP-1 projections are modelled on published clinical trial data from SURMOUNT and STEP studies.
All data stays on your device. We don't require sign-ups, and we don't store your health information on any server. Your progress tracker saves data locally in your browser using localStorage, so only you can see it.
We're based in the UK and our tools are designed specifically for UK users — supporting stone & lbs by default, referencing NHS guidelines, using NICE-approved medication data, and linking to GPhC-registered pharmacies.
Frequently Asked Questions
Common questions about BMI, weight loss medications, and our free UK tools.
Can Mounjaro cause kidney pain?
Kidney pain is not a listed common side effect of Mounjaro in UK clinical data. However, abdominal and stomach pain do affect more than 1 in 10 users. Pain in the sides or lower back should be investigated by your GP to rule out kidney stones, urinary tract infection, or other causes. Dehydration from Mounjaro side effects can affect kidney function, so staying well-hydrated is important.
What kidney problems might develop with Mounjaro?
Severe kidney disease may require Mounjaro dose adjustment or mean the medication is unsuitable. GLP-1 and GIP agonists typically show protective effects on kidney function in research. Before starting, your prescriber will check kidney function via blood tests. gradual weight management and dehydration can temporarily affect kidney filtering, so adequate water intake is essential throughout treatment.
How is kidney function checked before starting Mounjaro?
Your GP or online prescriber will request blood tests measuring creatinine and eGFR (estimated glomerular filtration rate) to assess kidney function. These results determine your eligibility for Mounjaro and the appropriate starting dose. If you have moderate to severe kidney disease, your prescriber will discuss whether Mounjaro is suitable or if dosing adjustments are needed.
What symptoms suggest I should contact my GP about kidney concerns?
Seek medical advice if you experience severe or persistent pain in the sides or lower back, changes in urination frequency or colour, blood in urine, fever alongside pain, or swelling in the legs and ankles. These may indicate kidney stones, infection, or kidney disease and require prompt investigation. Do not wait—contact your GP or NHS 111 if symptoms are severe.
Does Mounjaro help or harm kidney health long-term?
Research on GLP-1 and GIP agonists suggests kidney-protective effects, particularly in people with diabetes. Mounjaro is not expected to harm kidney function in people with normal or mildly reduced kidney function. However, adequate hydration, regular monitoring if you have kidney disease, and prompt medical attention for kidney-related symptoms are all important for safe use.
Ready to take control of your weight loss journey?
Start with a free BMI check, explore your GLP-1 options, or begin tracking your progress today. No sign-up. No cost. Just results.